Skip to main content
. Author manuscript; available in PMC: 2008 Dec 1.
Published in final edited form as: Bone. 2007 Aug 8;41(6):1036–1044. doi: 10.1016/j.bone.2007.07.018

Figure 1.

Figure 1

Serum ALP (U/L) (Colorimetric method), intact PTH (pg/L), sRANKL (pmol/L), OPG (pmol/L), and TRAP5b (U/L) (ELISAs) mean ± SD, n = 6 per treatment/control group. * = significant difference (p < 0.05) between F treatment group and control (0ppm) group. White boxes (0ppm), light grey (50ppm), and dark grey (100ppm)